INOZYME

Serial Number 90439231
Registration 8069672
700

Registration Progress

Application Filed
Dec 31, 2020
Under Examination
May 17, 2022
Approved for Publication
Mar 22, 2022
Published for Opposition
Mar 22, 2022
Registered
Dec 16, 2025

Trademark Image

INOZYME

Basic Information

Serial Number
90439231
Registration Number
8069672
Filing Date
December 31, 2020
Registration Date
December 16, 2025
Published for Opposition
March 22, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 16, 2025
Registration
Registered
Classes
005

Rights Holder

Inozyme Pharma, Inc.

03
Address
321 Summer Street, Suite 400
Boston, MA 02210

Ownership History

Inozyme Pharma, Inc.

Original Applicant
03
Boston, MA

Inozyme Pharma, Inc.

Owner at Publication
03
Boston, MA

Inozyme Pharma, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

Next Deadline
2180 days remaining
Section 8 Declaration Due (Principal Register) (Based on R.PRA event 2025-12-16)
Due Date
December 16, 2031
Grace Period Ends
June 16, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

48 events
Date Code Type Description Documents
Dec 16, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 16, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 26, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 26, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 21, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 15, 2025 IUAF S USE AMENDMENT FILED Loading...
Oct 21, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 19, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 19, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 19, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 19, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 19, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 15, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 7, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 7, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 7, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 7, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 14, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 13, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 13, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
May 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 18, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 16, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 16, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 16, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 18, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 16, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 16, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
May 16, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 4, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 2, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 2, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 2, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 17, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 17, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 26, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 19, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 18, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 18, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 15, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 15, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 15, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 7, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 4, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
therapeutic pharmaceutical for the diagnosis and treatment of diseases or disorders afflicting the bone, kidney and tissue, diseases of abnormal mineralization and calcification, diseases of the circulatory system, diseases caused by inborn errors of metabolism, and diseases caused by abnormal intimal proliferation; pharmaceutical products for use in the diagnosis and treatment of bone, kidney and tissue diseases, diseases of abnormal mineralization and calcification, diseases of the circulatory system, diseases caused by inborn errors of metabolism, and diseases caused by abnormal intimal proliferation
First Use Anywhere: Apr 11, 2025
First Use in Commerce: Apr 11, 2025

Classification

International Classes
005